ReviewChemMedChem2026
Metalloids: Semi as Metals yet Full of Antimicrobial Potential.
Review in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the periodic table, the metalloids boron (B), silicon (Si), germanium (Ge), arsenic (As), antimony (Sb), and tellurium (Te) demarcate a borderline between the metals and non-metals. Also referred to as semi-metals, their behaviour is indeed characterized by inorganic ions, organometallic complexes, and covalent compounds. Yet despite this unique medley of inorganic and organic molecules, reactivities and activities, and century-old traditional uses, their pharmaceutical applications today are often underestimated or associated with outright toxicity. Still, recent research has taken a closer look at (some of) these elements and has encountered an amazing assortment of natural metalloid-containing products, many with distinct antimicrobial activities. At the same time, metalloid-containing complexes have been synthesized and tested successfully as ionophores, in ligand-exchange reactions with amino acids, such as cysteine, or as redox modulators triggering oxidative stress. This has been complemented by an extensive synthesis of organic metalloid-based compounds, even including bioisosteric replacements for carbon. Today, a few metalloid compounds are still or already used in therapy; others are in clinical trials, and many more are in the pipeline, clearly demanding full attention for the semi-metals and their many colourful compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.